Finasteride has 6 percent less men develop prostate cancer than the ones who just took the placebo.
Finasteride has 6 percent less men develop prostate cancer than the ones who just took the placebo.
About 18 percent of men taking finasteride developed prostate cancer, compared with 24 percent on placebo.